ECSP12011569A - Derivados de pirazoles, su preparación y su aplicación terapéutica - Google Patents

Derivados de pirazoles, su preparación y su aplicación terapéutica

Info

Publication number
ECSP12011569A
ECSP12011569A EC2012011569A ECSP12011569A ECSP12011569A EC SP12011569 A ECSP12011569 A EC SP12011569A EC 2012011569 A EC2012011569 A EC 2012011569A EC SP12011569 A ECSP12011569 A EC SP12011569A EC SP12011569 A ECSP12011569 A EC SP12011569A
Authority
EC
Ecuador
Prior art keywords
preparation
derivatives
pirazoles
therapeutic application
application
Prior art date
Application number
EC2012011569A
Other languages
English (en)
Inventor
Michel Tabart
Pascal Desmazeau
Pierre Yves Abecassis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ECSP12011569A publication Critical patent/ECSP12011569A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere los derivados de pirazoles de la fórmula general (I) en la que: en donde X representa cloro o flúor. Procedimiento de preparación y aplicación en terapéutica
EC2012011569A 2009-07-03 2012-01-03 Derivados de pirazoles, su preparación y su aplicación terapéutica ECSP12011569A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903270A FR2947546B1 (fr) 2009-07-03 2009-07-03 Derives de pyrazoles, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ECSP12011569A true ECSP12011569A (es) 2012-02-29

Family

ID=41695643

Family Applications (2)

Application Number Title Priority Date Filing Date
ECSP12011659 ECSP12011659A (es) 2009-07-03 2012-01-03 Formulaciones orales sólidas y formas cristalinas de un inhibidor de la proteína de apoptosis
EC2012011569A ECSP12011569A (es) 2009-07-03 2012-01-03 Derivados de pirazoles, su preparación y su aplicación terapéutica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ECSP12011659 ECSP12011659A (es) 2009-07-03 2012-01-03 Formulaciones orales sólidas y formas cristalinas de un inhibidor de la proteína de apoptosis

Country Status (30)

Country Link
US (1) US8367715B2 (es)
EP (1) EP2448924B1 (es)
JP (1) JP5680640B2 (es)
KR (1) KR20120037967A (es)
CN (1) CN102471280B (es)
AR (1) AR077371A1 (es)
AU (1) AU2010267824A1 (es)
BR (1) BR112012000104A2 (es)
CA (1) CA2767096A1 (es)
CL (1) CL2012000013A1 (es)
CO (1) CO6480992A2 (es)
CR (1) CR20110701A (es)
DO (1) DOP2012000001A (es)
EA (1) EA020364B1 (es)
EC (2) ECSP12011659A (es)
FR (1) FR2947546B1 (es)
IL (1) IL217300A0 (es)
MA (1) MA33500B1 (es)
MX (1) MX2012000267A (es)
MY (1) MY155829A (es)
NI (1) NI201200001A (es)
NZ (1) NZ597578A (es)
PE (1) PE20120917A1 (es)
SG (1) SG177463A1 (es)
TN (1) TN2011000658A1 (es)
TW (1) TWI471312B (es)
UA (1) UA106500C2 (es)
UY (1) UY32757A (es)
WO (1) WO2011001122A2 (es)
ZA (1) ZA201200027B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908409B1 (fr) 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
WO2013106432A1 (en) * 2012-01-09 2013-07-18 X-Rx, Inc. Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
AR094812A1 (es) 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
KR102344105B1 (ko) 2014-08-18 2021-12-29 에자이 알앤드디 매니지먼트 가부시키가이샤 모노시클릭 피리딘 유도체의 염 및 이의 결정
EP3275442B1 (en) 2015-03-25 2021-07-28 National Cancer Center Therapeutic agent for bile duct cancer
CN108367000A (zh) 2015-12-17 2018-08-03 卫材R&D管理有限公司 用于乳腺癌的治疗剂
CN107619388A (zh) 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用
US11219619B2 (en) 2018-03-28 2022-01-11 Eisai R&D Management Co., Ltd. Therapeutic agent for hepatocellular carcinoma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331541B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
GB0317127D0 (en) * 2003-07-22 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
EP1845975A1 (en) * 2005-01-21 2007-10-24 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors and further antitumor agents
WO2007064931A2 (en) * 2005-12-02 2007-06-07 Bayer Healthcare Llc Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
US20070208000A1 (en) * 2005-12-15 2007-09-06 Morgan Bradley P Certain chemical entities, compositions and methods
EP1959947A2 (en) * 2005-12-15 2008-08-27 Cytokinetics, Inc. Certain chemical entities, compositions and methods
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
WO2008073480A1 (en) * 2006-12-11 2008-06-19 Irm Llc Compounds and compositions as kinase inhibitors

Also Published As

Publication number Publication date
UA106500C2 (uk) 2014-09-10
PE20120917A1 (es) 2012-08-17
NI201200001A (es) 2012-03-30
WO2011001122A3 (fr) 2011-02-24
ZA201200027B (en) 2013-03-27
HK1169387A1 (en) 2013-01-25
JP5680640B2 (ja) 2015-03-04
CO6480992A2 (es) 2012-07-16
FR2947546B1 (fr) 2011-07-01
US8367715B2 (en) 2013-02-05
ECSP12011659A (es) 2012-03-30
CN102471280B (zh) 2014-08-06
MX2012000267A (es) 2012-04-30
EP2448924B1 (fr) 2013-09-04
EA201270128A1 (ru) 2012-07-30
CL2012000013A1 (es) 2012-09-14
MY155829A (en) 2015-12-15
CN102471280A (zh) 2012-05-23
EP2448924A2 (fr) 2012-05-09
KR20120037967A (ko) 2012-04-20
EA020364B1 (ru) 2014-10-30
MA33500B1 (fr) 2012-08-01
TN2011000658A1 (fr) 2013-05-24
DOP2012000001A (es) 2012-01-31
TW201107298A (en) 2011-03-01
FR2947546A1 (fr) 2011-01-07
NZ597578A (en) 2013-11-29
TWI471312B (zh) 2015-02-01
JP2012531466A (ja) 2012-12-10
BR112012000104A2 (pt) 2016-03-15
US20120270918A1 (en) 2012-10-25
AU2010267824A1 (en) 2012-02-16
SG177463A1 (en) 2012-02-28
IL217300A0 (en) 2012-02-29
CA2767096A1 (fr) 2011-01-06
WO2011001122A2 (fr) 2011-01-06
UY32757A (es) 2011-01-31
AR077371A1 (es) 2011-08-24
CR20110701A (es) 2012-03-06

Similar Documents

Publication Publication Date Title
ECSP12011569A (es) Derivados de pirazoles, su preparación y su aplicación terapéutica
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
UY31037A1 (es) Derivados de triazolopiridin-carboxamidas, su preparacion y su aplicacion en terapeutica
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
UY33735A (es) Compuestos antivirales
UY31032A1 (es) Derivados de triazolopiridin-carboxamidas y triazolopirimidin-carboxinamidas, su preparacion y su aplicacion en terapeutica
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
DOP2011000245A (es) Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapeutica
EA201270255A1 (ru) 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные
UY31689A1 (es) Derivados de platino-carbeno n-heterocíclico, su preparación y su aplicación en terapéutica
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
CR20110246A (es) Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica.
ECSP12011971A (es) NUEVOS DERIVADOS (HETEROCICLO-TETRAHIDRO-PIRIDIN)-(PIPERAZINIL)-1-ALCANONA Y (HETEROCICLO-DIHIDRO-PIRROLIDIN)-(PIPERAZINIL)-1-ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
CY1112855T1 (el) Παραγωγα των πυρρολοπυριδινο-2-καρβοξαμιδιων, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
CR10969A (es) Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica
ECSP10010292A (es) Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY32515A (es) Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica
UY29921A1 (es) Derivados de 3-acilindol, su preparación y su aplicación en terapéutica
UY29858A1 (es) Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica